Human settlements represent a specific environment where commensal animals are exposed to different selective pressures than their wild-living conspecifics. Despite the importance of commensal rodents for human health and economy, little is known about how a transition to a commensal way of life changes the behaviour of the animals. We tested twelve populations of spiny mice (Acomys spp.) in two open field-type tests - a vertical test and a hole board test. In the vertical test, a wire mesh for climbing was offered to spiny mice. We used a multipopulation approach using two commensal and ten non-commensal spiny mouse populations to account for inter-population variability. We aimed to investigate whether there are differences in behaviour of commensal and non-commensal populations with special regard to their exploratory activity both on the ground and on the wire mesh. We found that all non-commensal populations behaved similarly despite their long separate evolutionary histories. Contrary, the commensal populations were less exploratory on the ground in both tests. We concluded that this change was associated with their transition to commensalism. This shows that selective pressures of the commensal environment are able to induce noticeable changes in behaviour after a very short evolutionary time.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.beproc.2020.104252 | DOI Listing |
J Intellect Dev Disabil
March 2021
Center for Interdisciplinary Research in Rehabilitation and Social Integration, Québec City, Canada.
This article aims to present the results of a study on the facilitators and obstacles to community participation in inclusive settings for people with intellectual disabilities (ID) in Québec City (Canada), as perceived by adults with ID and key individuals involved in their daily lives. Semi-structured interviews were conducted, followed by an inductive thematic analysis process. Twenty participants shared their perspectives on the factors that influence community participation of adults with ID in inclusive settings.
View Article and Find Full Text PDFDisabil Health J
January 2025
Institute for Exceptional Care, 1717 K Street NW, Suite 900, Washington, DC, 20006, USA. Electronic address:
Background: Persons with intellectual and/or developmental disabilities (IDD) are a growing population, frequently living with complex health conditions and unmet healthcare needs. Traditional clinical practice and research methods and measures may require adaptation to reflect their preferences.
Objective: The perspectives of people with IDD, caregivers/partners, and clinicians were obtained to provide insight into factors contributing to the health and wellness of people with IDD.
J Neurosci Res
January 2025
Department of Psychology, University of Regensburg, Regensburg, Germany.
Anxiety and depression disorders show high prevalence rates, and stress is a significant risk factor for both. However, studies investigating the interplay between anxiety, depression, and stress regulation in the brain are scarce. The present manuscript included 124 law students from the LawSTRESS project.
View Article and Find Full Text PDFJ Adv Nurs
January 2025
Independant Scholar.
Aim: To explore psychiatric and mental health nurses' perceptions of patients with co-occurring psychiatric and substance use disorders in psychiatric settings.
Design: An exploratory qualitative study design based on grounded theory, employing Straussian analytic procedures.
Method: Semi-structured interviews were conducted with 11 psychiatric and mental health nurses.
Introduction: Age-associated depletion in nicotinamide adenine dinucleotide (NAD+) concentrations has been implicated in metabolic, cardiovascular, and neurodegenerative disorders. Supplementation with NAD+ precursors, such as nicotinamide riboside (NR), offers a potential therapeutic avenue against neurodegenerative pathologies in aging, Alzheimer's disease, and related dementias. A crossover, double-blind, randomized placebo (PBO) controlled trial was conducted to test the safety and efficacy of 8 weeks' active treatment with NR (1 g/day) on cognition and plasma AD biomarkers in older adults with subjective cognitive decline and mild cognitive impairment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!